Shanghai Stock Exchange

FULONGMA heralds Thailand's EV sanitation equipment breakthrough

Friday, September 17, 2021 - 3:34am

FULONGMA is proud to assist Thailand in its fight against climate and hopes to usher in a new era of EV sanitation vehicles.

Key Points: 
  • FULONGMA is proud to assist Thailand in its fight against climate and hopes to usher in a new era of EV sanitation vehicles.
  • The FULONGMA EV washing and sweeping truck, EV garbage compactor truck and EV water truck are pure electric vehicles, which have been manufactured in accordance with China's latest energy and climate policies.
  • This inaugural delivery of FULONGMA's EV sanitation products to Thailand, heralds a new dawn for EV sanitation equipment in the region and demonstrates the Company's strong international brand recognition.
  • The company is an environmental sanitation total solution provider, who integrates the urban and rural environmental sanitation systematic planning and design, sanitation project operating and investment.

Hua and Sinopharm Announced Supply Chain Strategic Cooperation

Wednesday, September 15, 2021 - 6:35am

SHANGHAI, CHINA, Sept 15, 2021 - (ACN Newswire) - On September 13, 2021, Hua Medicine (Shanghai) Ltd. (the "Hua Medicine", Stock Code: 2552.HK) has signed a supply chain strategic cooperation agreement with Sinopharm Group Co., Ltd. (the "Sinopharm", Stock Code: 1099).

Key Points: 
  • SHANGHAI, CHINA, Sept 15, 2021 - (ACN Newswire) - On September 13, 2021, Hua Medicine (Shanghai) Ltd. (the "Hua Medicine", Stock Code: 2552.HK) has signed a supply chain strategic cooperation agreement with Sinopharm Group Co., Ltd. (the "Sinopharm", Stock Code: 1099).
  • Hua Medicine will rely on Sinopharm's nation-wide drug distribution network to carry out in-depth cooperation in supply chain management.
  • "We are very glad to witness the strategic cooperation between Sinopharm and Hua Medicine, opening a new chapter on our cooperation.
  • In recent years, Sinopharm continue to innovate and build up the new ecosystem of the smart pharmaceutical and supply chain, improving the efficiency of supply chain.

MP Materials Announces Pricing of Upsized Secondary Public Offering of Common Stock by Selling Stockholders

Tuesday, September 14, 2021 - 1:00pm

MP Materials Corp. (NYSE: MP) (MP Materials or the Company), today announced that on September 13, 2021, the Company priced its registered secondary public offering of 4,250,000 shares of common stock by certain existing stockholders of the Company (the Selling Stockholders) at a price to the public of $35.00 per share.

Key Points: 
  • MP Materials Corp. (NYSE: MP) (MP Materials or the Company), today announced that on September 13, 2021, the Company priced its registered secondary public offering of 4,250,000 shares of common stock by certain existing stockholders of the Company (the Selling Stockholders) at a price to the public of $35.00 per share.
  • This represents an increase of 250,000 shares from the previously announced offering size of 4,000,000 shares of common stock.
  • The underwriters have a 30-day option to purchase up to an additional 637,500 shares of common stock from the Selling Stockholders.
  • MP Materials Corp. (NYSE: MP) is the largest producer of rare earth materials in the Western Hemisphere.

MP Materials Announces Proposed Secondary Public Offering of Common Stock by Selling Stockholders

Monday, September 13, 2021 - 9:20pm

MP Materials Corp. (NYSE: MP) (MP Materials or the Company), today announced the commencement, subject to market and other conditions, of a proposed registered secondary public offering of 4,000,000 shares of common stock by certain existing stockholders of the Company (the Selling Stockholders).

Key Points: 
  • MP Materials Corp. (NYSE: MP) (MP Materials or the Company), today announced the commencement, subject to market and other conditions, of a proposed registered secondary public offering of 4,000,000 shares of common stock by certain existing stockholders of the Company (the Selling Stockholders).
  • The underwriters will have a 30-day option to purchase up to an additional 600,000 shares of common stock from Selling Stockholders.
  • MP Materials is not selling any shares of common stock and will not receive any proceeds from the proposed offering.
  • The proposed offering will not change the number of shares of common stock that are currently outstanding.

HUTCHMED Receives Breakthrough Therapy Designation in China for Amdizalisib (HMPL-689) for Treatment of Relapsed or Refractory Follicular Lymphoma

Monday, September 13, 2021 - 7:00am

This indicates that the development and review of amdizalisib for relapsed or refractory FL may be expedited, to address patients' unmet needs more quickly.

Key Points: 
  • This indicates that the development and review of amdizalisib for relapsed or refractory FL may be expedited, to address patients' unmet needs more quickly.
  • In April 2021, HUTCHMED initiated a Phase II registration study in China for amdizalisib in approximately 100 patients with relapsed or refractory FL and approximately 80 patients with marginal zone lymphoma (MZL).
  • Amdizalisib is also being evaluated in an ongoing Phase I/Ib study in the U.S. and Europe in patients with relapsed or refractory NHL ( NCT03786926 ).
  • Patients with relapsed or refractory FL do not have curative treatment options and have a high unmet need for optimal therapeutic options.

Tangram Launches Sales Within Its Second Residential Tower, Tangram House West

Wednesday, September 8, 2021 - 4:23pm

Infused withmodernelegance,Tangram House West was designed by award-winningArchitect andInteriorDesigner Jean-Gabriel Neukommof JG Neukomm.The aestheticwas inspired bytranquil and invitingmodernismviastudio, one and two-bedroomresidences offering sweeping Manhattan skylineorlush garden views.

Key Points: 
  • Infused withmodernelegance,Tangram House West was designed by award-winningArchitect andInteriorDesigner Jean-Gabriel Neukommof JG Neukomm.The aestheticwas inspired bytranquil and invitingmodernismviastudio, one and two-bedroomresidences offering sweeping Manhattan skylineorlush garden views.
  • In addition, 27 grand penthouses (one, two, three and four-bedroom) include upgraded appliances andfinishesthatmaintain the same organic sensibilitiesintegralof Tangram House'sdesign.
  • "Afterthe immense success ofthe residentialTangram House South's quick sell outafter launching in 2017,we're looking forward towelcoming an equally eager group of buyers toTangram House West.
  • Adding to its tranquility,Tangram House West's unique3,500-square-foot Pavilion sits at the heart ofitsone acre ofalush walking garden.

HUTCHMED Announces Selection of Its Shares in the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs

Monday, September 6, 2021 - 7:00am

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Sept. 06, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ( HUTCHMED ) (Nasdaq/AIM: HCM; HKEX: 13) today announces that the Companys ordinary shares, which trade on The Stock Exchange of Hong Kong Limited (HKEX), are included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective on September 6, 2021, according to announcements issued by the Shanghai Stock Exchange and the Shenzhen Stock Exchange.

Key Points: 
  • HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Sept. 06, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ( HUTCHMED ) (Nasdaq/AIM: HCM; HKEX: 13) today announces that the Companys ordinary shares, which trade on The Stock Exchange of Hong Kong Limited (HKEX), are included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, effective on September 6, 2021, according to announcements issued by the Shanghai Stock Exchange and the Shenzhen Stock Exchange.
  • The Stock Connect programs allow international and Mainland Chinese investors to trade securities in each other's markets through the trading and clearing facilities of HKEX, Shanghai and Shenzhen Stock Exchanges.
  • Qualified Mainland Chinese investors can access eligible Hong Kong shares (Southbound), while Hong Kong and overseas investors can trade eligible A shares (Northbound), subject to specified daily quotas.
  • Inclusion in the Hang Seng Composite Index is a key requirement for the Stock Connect scheme.

Colt adds seven Mainland China Exchanges to its Market Data Services Portfolio

Tuesday, August 31, 2021 - 2:00am

TOKYO, Aug 31, 2021 - (ACN Newswire) - Colt Technology Services today announced the expansion of its portfolio of Market Data services to incorporate Mainland China.

Key Points: 
  • TOKYO, Aug 31, 2021 - (ACN Newswire) - Colt Technology Services today announced the expansion of its portfolio of Market Data services to incorporate Mainland China.
  • This new and unique proposition, available in Europe, North America and Asia, make Colt the only comprehensive provider of market data coverage for stock, futures and commodity exchanges across the country.
  • Market Data services for the Shanghai Futures Exchange (SHFE), Dalian Commodity Exchange (DCE) and Shanghai International Energy Exchange (INE) will be added in Q3 2021.
  • As a licensed market data provider, Colt offers raw and normalised feeds at consistently low latencies, even during periods of volatility.

BeyondSpring Announces Exclusive Commercialization and Co-development Agreement with Jiangsu Hengrui Pharmaceuticals for Plinabulin in Greater China

Thursday, August 26, 2021 - 12:00pm

Wanchunbulin and Hengrui will co-develop additional indications for plinabulin in the Territory; Hengrui funds 50% of future clinical development costs for new cancer indications in the Territory.

Key Points: 
  • Wanchunbulin and Hengrui will co-develop additional indications for plinabulin in the Territory; Hengrui funds 50% of future clinical development costs for new cancer indications in the Territory.
  • NEW YORK and SHANGHAI, China, Aug. 26, 2021 (GLOBE NEWSWIRE) -- BeyondSpring (the Company or BeyondSpring) (NASDAQ: BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (or Hengrui) today announced an exclusive commercialization and co-development agreement in Greater China (the Territory) for BeyondSpring's investigational drug candidate plinabulin, a first-in-class, selective immunomodulating microtubule-binding agent (SIMBA).
  • BeyondSpring will still retain 100% of the global plinabulin rights outside of Greater China.
  • Under the terms of the agreement, Wanchunbulin will grant Hengrui exclusive rights to commercialize and co-develop plinabulin in the Greater China markets, including mainland China, Hong Kong, Macau and Taiwan.

HUTCHMED Selected as Constituent of Certain Hang Seng Indexes

Monday, August 23, 2021 - 1:00am

HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Aug. 22, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ( HUTCHMED ) (Nasdaq/AIM: HCM; HKEX: 13) today announces that HUTCHMED has been selected as a constituent stock of several indexes administered by Hang Seng Indexes Company Limited (Hang Seng), including the Hang Seng Composite Index, in accordance with the latest index series release by Hang Seng, with effect from Monday, September 6, 2021.

Key Points: 
  • HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Aug. 22, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ( HUTCHMED ) (Nasdaq/AIM: HCM; HKEX: 13) today announces that HUTCHMED has been selected as a constituent stock of several indexes administered by Hang Seng Indexes Company Limited (Hang Seng), including the Hang Seng Composite Index, in accordance with the latest index series release by Hang Seng, with effect from Monday, September 6, 2021.
  • HUTCHMED has also been selected for six other indexes of Hong Kong-listed stocks, including the Hang Seng Healthcare Index and the Hang Seng Hong Kong-Listed Biotech Index.
  • In addition to the above indexes of stocks listed in Hong Kong, Hang Seng has also selected HUTCHMED for inclusion in six cross-market indexes, including the Hang Seng Stock Connect China 500 Index, which aims to measure the overall performance of the 500 largest Chinese companies in terms of market capitalization listed in Hong Kong and/or mainland China that are eligible for Northbound or Southbound trading under the Stock Connect schemes.
  • HUTCHMED undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise.